Register entryShortage reported

Kindos Pharmaceuticals Co., Ltd.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
1
Live patents
0
Shortage listings
5
Countries
0
Alert

Drug shortage listings

5
DrugPresentationStatusAvailabilityPosted / updated
Bupivacaine Hydrochloride InjectionAnesthesiaBupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)CurrentLimited Availability20 Feb 20185 May 2026
Bupivacaine Hydrochloride InjectionAnesthesiaBupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)CurrentLimited Availability20 Feb 20185 May 2026
Bupivacaine Hydrochloride InjectionAnesthesiaBupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)To Be Discontinued-5 May 20265 May 2026
Bupivacaine Hydrochloride InjectionAnesthesiaBupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)To Be Discontinued-5 May 20265 May 2026
Bupivacaine Hydrochloride InjectionAnesthesiaBupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)To Be Discontinued-5 May 20265 May 2026
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
ERIBULIN MESYLATEeribulin mesylateinjection, intravenous40033-364ANDA
Compare

Other companies listing eribulin mesylate

Enquiry

Common questions

Is Kindos Pharmaceuticals Co., Ltd. FDA approved?
Kindos Pharmaceuticals Co., Ltd. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Kindos Pharmaceuticals Co., Ltd. make?
1 product is listed under Kindos Pharmaceuticals Co., Ltd. in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Are any Kindos Pharmaceuticals Co., Ltd. products in shortage?
2 presentations are currently listed in the FDA drug shortage database under Kindos Pharmaceuticals Co., Ltd., covering Bupivacaine Hydrochloride Injection.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.